Anna is a financial writer for US and Chinese stocks and she also invests in the same. She was previously an investment banker in New York Hong Kong and London for 9 years, focused on Equity Capital Markets. She is …
Future earnings is a keyfactor, which eventually has a significant impact on the stock price. As per the brokerage houses predictions Amgen Inc. (NASDAQ:AMGN) stock can smash $181.7 in coming year. This …
Biotechnology, lately the stock market's laggard, may finally be on the mend. Amgen announced a highly anticipated clinical trial involving its new anti-cholesterol drug, Repatha, was successful in reducing the risk of …
Amgen
[PR Newswire] – YORK, Pa., Feb. 22, 2016 /PRNewswire/ — Unilife Corporation (NASDAQ: UNIS, ASX: UNS) …
The outcome of the so-called 'FOURIER' trial is extremely important for Amgen because the data will be used to lobby insurance companies to reimburse for Repatha. Cytokinetics, Achillion and Qiagen were among the …
Amgen
(The Motley Fool owns shares of and has recommended Apple.) With a market value recently topping $110 billion, biotechnology titan Amgen (Nasdaq: AMGN) is a blue-chip company whose stock has been held back by bad …
Motley Fool
Tapimmune, Inc. (NASDAQ: TPIV), AstraZeneca plc (NYSE: AZN), …
cancer
The Stock has YTD (year to date) performance of -0.05 percent. Amgen …
Kraft Foods
The Company gained 1.02% and finished at $150.18. The daily volume was measured at 3.07 million shares. The 52-week high of the share price is $181.81 and the 52-week low is $130.09. The company has a market cap of …
Amgen, Inc. (NASDAQ:AMGN) yesterday announced that FDA has responded with a ... that Parsabiv miss is unlikely to cause any dramatic impact on the stock’s future. The investor circles have also been rather calm …
TCC5mon
Amgen